接种BCG疫苗会影响人类骨髓中原生细胞的表观遗传情景
Sarah J Sun1,2, Raúl Aguirre-Gamboa3, L Charlotte J de Bree4
1Committee on Immunology, University of Chicago, Chicago, IL, USA.
bioRxiv : the preprint server for biology
|December 11, 2023
概括
细菌-卡尔梅特-盖林 (BCG) 疫苗改变了人类干细胞的基因表达和表观遗传学,增强了髓质偏差并影响了免疫反应. 这为BCG提供了新的见解.
科学领域:
- 免疫学 免疫学 免疫学
- 血液形成 血液形成 血液形成
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 细菌-卡尔梅特-盖林 (BCG) 疫苗可以预防结核病,但也可以保护其他感染.
- 在人类中,BCG的广谱保护背后的机制,特别是它对免疫系统的基础细胞的影响,仍然不清楚.
研究的目的:
- 研究BCG疫苗接种对人类造血干细胞和原生细胞 (HSPCs) 的单细胞分离效应.
- 了解BCG对基因表达,染色体景观和先天免疫记忆的影响.
主要方法:
- 在BCG疫苗接种或安慰剂之前和90天后对人类骨髓样本的分析.
- 单细胞RNA测序和ATAC测序用于调查基因表达和染色质可访问性.
- 在HSPC变化和外围血液单核细胞 (PBMC) 细胞因子分泌之间的相关性分析.
主要成果:
- 接种BCG疫苗会显著改变HSPC的基因表达和表观遗传特征,导致持续的髓状偏差.
- 染色质可访问性的变化在差异化的原始细胞中突出,由转录因子 (KLF/SP,EGR) 驱动,这些转录因子也在干细胞中活跃.
- 在二次免疫挑战时,HSPC变化与增强的IL-1β分泌能力有很强的相关性.
结论:
- 接种BCG疫苗会诱导HSPCs的持久变化,挑战直接干系到衍生物的表观遗传记忆传输模型.
- 这些HSPC修改与改善的先天免疫反应有关,这解释了BCG保护作用的一部分.
- 研究结果揭示了BCG对免疫系统早期细胞组成部分的显著影响.
更多相关视频
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
7.9K
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
6.2K
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
